Skip to main content
DHR logo

Danaher Corporation

DHRNYSEHealthcareDiagnostics & Research

$230.50Today:- (-)1Y +3.15%

As of Oct 23, 2026 close

Market cap
$163.10B
P/E (TTM)
40.73
Forward P/E
34.77
Dividend yield
0.66%
52-week range
$160.93$242.80
Volume (live)
-
Avg. volume (3M)
4.86M

Danaher (DHR) Stock Price & Financial Analysis

Danaher Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$225.60 - $230.66
52-Week High$242.80
52-Week Low$160.93
Open$229.17
Volume (last close)3.94M
Average Volume (3M)4.86M
Earnings & Profitability
Revenue (TTM)25.11B
Net Income (TTM)4.00B
Free Cash Flow (TTM)5.47B
EPS (TTM)$5.63
Profit Margin15.95%
Operating Margin20.42%
Return on Equity (ROE)7.61%
Debt to Equity0.51
Dividend Information
Annual Dividend$1.52
Dividend Yield0.66%
Payout Ratio26.99%
Last Dividend Ex-DateSep 30, 2026
Size & Valuation
Market Cap163.10B
Shares Outstanding707.60M
P/E Ratio (TTM)40.73
Forward P/E34.77
Price to Sales (P/S)6.50
Price to Book (P/B)3.10
EV/EBITDA24.36
Technical Indicators
50-Day MA$214.59
200-Day MA$201.27
1-Year Change+3.15%

Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology

Compare DHR with other stocks

Danaher at a Glance

As of the Oct 23, 2026 close, Danaher (DHR) has a market capitalization of $163.10B. The stock trades at 40.7× trailing earnings, 34.8× forward earnings and 6.5× sales. Over the trailing twelve months it earned $4.00B on revenue of $25.11B (a 15.9% profit margin) and generated $5.47B of free cash flow. Revenue grew 4.6% year over year.

As of its latest reported balance sheet, it holds $4.35B in cash and securities against $26.56B of debt, a net debt position of $22.21B.

Danaher pays a quarterly dividend totaling $1.52 per share a year, a 0.66% yield at the Oct 23, 2026 close, with a 27% payout ratio and 12 consecutive years of dividend increases.

The share price is up 3.2% over the past year. At $230.50 (the Oct 23, 2026 close) it sits within its 52-week range of $160.93 to $242.80, above its 200-day moving average of $201.27.

Based on 17 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $254.60, 10.5% above the Oct 23, 2026 close.

Frequently Asked Questions About Danaher

What is the current stock price for DHR?

As of the Oct 23, 2026 close, DHR stock trades at $230.50. The 52-week range is $160.93–$242.80, with a day range of $225.60–$230.66.

What is the P/E ratio for DHR?

As of the Oct 23, 2026 close, Danaher's trailing twelve-month (TTM) P/E ratio is 40.7, meaning investors pay $40.7 for every $1 of annual earnings. The forward P/E is 34.8, reflecting analyst expectations for future earnings. Danaher operates in the Healthcare sector.

Does DHR pay dividends?

Yes, Danaher pays a 0.66% annual dividend yield as of the Oct 23, 2026 close ($1.52 per share a year). The trailing twelve-month payout ratio is 27.0%. The most recent ex-dividend date was September 30, 2026.

What do analysts recommend for DHR?

Based on ratings from 17 professional analysts over the last 90 days, the consensus for DHR is Buy. The average 12-month price target is $254.60, a 10.5% upside from the Oct 23, 2026 close of $230.50.

What is the market cap of DHR?

As of the Oct 23, 2026 close, Danaher's market capitalization is $163.10B, classifying it as a large-cap company. Danaher operates in the Healthcare sector within the Diagnostics & Research industry.